UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Precueing attention to the target location diminishes crowding and reduces the critical distance

Journal of vision (Charlottesville, Va.), 2010-08, Vol.10 (10), p.16-16

2010

Volltextzugriff (PDF)

Contrast dissimilarity effects on crowding are not simply another case of target saliency

Journal of vision (Charlottesville, Va.), 2014-12, Vol.14 (6), p.9-9, Article 1

2014

Volltextzugriff (PDF)

Spatial and temporal crowding with normal observers

Journal of vision (Charlottesville, Va.), 2014-08, Vol.14 (10), p.778-778

2014

Volltextzugriff (PDF)

Can a competition between grouping principles be resolved without attention?

Journal of vision (Charlottesville, Va.), 2014-08, Vol.14 (10), p.805-805

2014

Volltextzugriff (PDF)

The effects of transient attention and target contrast on crowding at different eccentricities

Journal of vision (Charlottesville, Va.), 2010-09, Vol.9 (8), p.994-994

2010

Volltextzugriff (PDF)

The effects of transient attention and target contrast on crowding at different eccentricities

Journal of vision (Charlottesville, Va.), 2010-09, Vol.9 (8), p.993-993

2010

Volltextzugriff (PDF)

Temporal crowding with normal observers and its interplay with spatial crowding

Journal of vision (Charlottesville, Va.), 2010-08, Vol.10 (7), p.1343-1343

2010

Volltextzugriff (PDF)

Competition Between Grouping Principles

Journal of vision (Charlottesville, Va.), 2013-07, Vol.13 (9), p.823-823

2013

Volltextzugriff (PDF)

Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies

Gynecologic oncology, 2020-02, Vol.156 (2), p.308-314

2020

Volltextzugriff (PDF)

Nuclear Export Inhibition for Radiosensitization; a Proof-of-Concept Phase I Clinical Trial of Neoadjuvant KPT-330 Plus Chemoradiation in Locally Advanced Rectal Cancer

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e10-e10

2018

Volltextzugriff (PDF)

247 Selective inhibitors of nuclear export (SINE) block the expression of DNA damage repair proteins and sensitize cancer cells to DNA damage therapeutic agents

European journal of cancer (1990), 2014-11, Vol.50, p.83-83

2014

Volltextzugriff (PDF)

Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination with Fludarabine and Cytarabine in Pediatric Patients with Relapsed or Refractory AML

Blood, 2015-12, Vol.126 (23), p.1345-1345

2015

Volltextzugriff (PDF)

Selinexor-Induced Thrombocytopenia Results from the Inhibition of Megakaryocyte Progenitor Cells in the Early Stage of Megakaryopoiesis

Blood, 2014-12, Vol.124 (21), p.1458-1458

2014

Volltextzugriff (PDF)

Phase 1 MMRC Trial of Selinexor, Carfilzomib (CFZ), and Dexamethasone (DEX) in Relapsed and Relapsed/Refractory Multiple Myeloma (RRMM)

Blood, 2015-12, Vol.126 (23), p.4223-4223

2015

Volltextzugriff (PDF)

Circulating tumor cell number predicts time to progression (TTP) in patients with heavily pretreated gynecological cancers treated with selinexor (SEL)

Annals of oncology, 2016-10, Vol.27, p.vi305-vi305

2016

Volltextzugriff (PDF)

Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers

Annals of oncology, 2016-10, Vol.27, p.vi296-vi296

2016

Volltextzugriff (PDF)

Preclinical and Early Clinical Activity of the Oral Selective Inhibitor of Nuclear Export (Sine) Exportin 1 (Xpo1) Antagonist Selinexor (Kpt-330) in Patients (Pts) with Platinum Resistant/Refractory Ovarian Cancer (Ovca)

Annals of oncology, 2014-09, Vol.25, p.iv310

2014

Volltextzugriff (PDF)

888PPRECLINICAL AND EARLY CLINICAL ACTIVITY OF THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) EXPORTIN 1 (XPO1) ANTAGONIST SELINEXOR (KPT-330) IN PATIENTS (PTS) WITH PLATINUM RESISTANT/REFRACTORY OVARIAN CANCER (OVCA)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv310-iv310

2014

Volltextzugriff (PDF)

994PDCLINICAL ACTIVITY OF THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SELINEXOR (KPT-330) IN PATIENTS WITH HEAD & NECK SQUAMOS CELL CARCINOMA (HN-SCC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv343-iv343

2014

Volltextzugriff (PDF)

758OSELINEXOR (KPT-330), AN ORAL, SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SHOWS ANTI-PROSTATE CANCER (PRCA) ACTIVITY PRECLINICALLY & DISEASE CONTROL IN PATIENTS (PTS) WITH CHEMOTHERAPY REFRACTORY, CASTRATE-RESISTANT PROSTATE CANCER (CRPC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv257-iv257

2014

Volltextzugriff (PDF)

Selinexor (Kpt-330), an Oral, Selective Inhibitor of Nuclear Export (Sine) Shows Anti-Prostate Cancer (Prca) Activity Preclinically & Disease Control in Patients (Pts) with Chemotherapy Refractory, Castrate-Resistant Prostate Cancer (Crpc)

Annals of oncology, 2014-09, Vol.25, p.iv257

2014

Volltextzugriff (PDF)

Clinical Activity of the Oral Selective Inhibitor of Nuclear Export (Sine) Selinexor (Kpt-330) in Patients with Head & Neck Squamos Cell Carcinoma (Hn-Scc)

Annals of oncology, 2014-09, Vol.25, p.iv343

2014

Volltextzugriff (PDF)

A phase 1 dose-escalation study of the oral selective inhibitor of nuclear export (SINE) KPT-330 (selinexor) in patients (pts) with relapsed/refractory acute myeloid leukemia (AML)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7032-7032

2014

Volltextzugriff (PDF)

A phase 1 dose-escalation study of the oral selective inhibitor of nuclear export (SINE) KPT-330 (selinexor) in patients (pts) with heavily pretreated non-Hodgkin lymphoma (NHL)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8518-8518

2014

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(4)
Science & Technology
(4)
Humans
(3)
Attention - Physiology
(2)
Critical Distance
(2)
Crowding
(2)
Ophthalmology
(2)
Pattern Recognition, Visual - Physiology
(2)
Adult
(1)
Aged
(1)
Aged, 80 And Over
(1)
Agricultural Sciences
(1)
Agriculture
(1)
Agronomy
(1)
Attention
(1)
Blumeria Graminis F. Sp. Hordei
(1)
Cervical Cancer
(1)
Cohort Studies
(1)
Contrast
(1)
Contrast Sensitivity - Physiology
(1)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(26)
Journals@Ovid Full Text
(10)
Publisher or Other Site
(10)
Ingenta
(4)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(3)
MEDLINE
(3)
Elsevier ScienceDirect Journals
(3)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(8)
Journal Of Vision
(8)
Blood
(7)
Journal Of Clinical Oncology
(2)
Agronomie
(1)
European Journal Of Cancer
(1)
Gynecologic Oncology
(1)
International Journal Of Radiation Oncology, Biology, Physics
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Precueing attention to the target location diminishes crowding and reduces the critical distance

Contrast dissimilarity effects on crowding are not simply another case of target saliency

Spatial and temporal crowding with normal observers

Can a competition between grouping principles be resolved without attention?

The effects of transient attention and target contrast on crowding at different eccentricities

The effects of transient attention and target contrast on crowding at different eccentricities

Temporal crowding with normal observers and its interplay with spatial crowding

Competition Between Grouping Principles

Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies

Nuclear Export Inhibition for Radiosensitization; a Proof-of-Concept Phase I Clinical Trial of Neoadjuvant KPT-330 Plus Chemoradiation in Locally Advanced Rectal Cancer

247 Selective inhibitors of nuclear export (SINE) block the expression of DNA damage repair proteins and sensitize cancer cells to DNA damage therapeutic agents

Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination with Fludarabine and Cytarabine in Pediatric Patients with Relapsed or Refractory AML

Selinexor-Induced Thrombocytopenia Results from the Inhibition of Megakaryocyte Progenitor Cells in the Early Stage of Megakaryopoiesis

Phase 1 MMRC Trial of Selinexor, Carfilzomib (CFZ), and Dexamethasone (DEX) in Relapsed and Relapsed/Refractory Multiple Myeloma (RRMM)

Circulating tumor cell number predicts time to progression (TTP) in patients with heavily pretreated gynecological cancers treated with selinexor (SEL)

Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers

Preclinical and Early Clinical Activity of the Oral Selective Inhibitor of Nuclear Export (Sine) Exportin 1 (Xpo1) Antagonist Selinexor (Kpt-330) in Patients (Pts) with Platinum Resistant/Refractory Ovarian Cancer (Ovca)

888PPRECLINICAL AND EARLY CLINICAL ACTIVITY OF THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) EXPORTIN 1 (XPO1) ANTAGONIST SELINEXOR (KPT-330) IN PATIENTS (PTS) WITH PLATINUM RESISTANT/REFRACTORY OVARIAN CANCER (OVCA)

994PDCLINICAL ACTIVITY OF THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SELINEXOR (KPT-330) IN PATIENTS WITH HEAD & NECK SQUAMOS CELL CARCINOMA (HN-SCC)

758OSELINEXOR (KPT-330), AN ORAL, SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SHOWS ANTI-PROSTATE CANCER (PRCA) ACTIVITY PRECLINICALLY & DISEASE CONTROL IN PATIENTS (PTS) WITH CHEMOTHERAPY REFRACTORY, CASTRATE-RESISTANT PROSTATE CANCER (CRPC)

Selinexor (Kpt-330), an Oral, Selective Inhibitor of Nuclear Export (Sine) Shows Anti-Prostate Cancer (Prca) Activity Preclinically & Disease Control in Patients (Pts) with Chemotherapy Refractory, Castrate-Resistant Prostate Cancer (Crpc)

Clinical Activity of the Oral Selective Inhibitor of Nuclear Export (Sine) Selinexor (Kpt-330) in Patients with Head & Neck Squamos Cell Carcinoma (Hn-Scc)

Selinexor Demonstrates Marked Synergy with Dexamethasone (Sel-Dex) in Preclinical Models and in Patients with Heavily Pretreated Refractory Multiple Myeloma (MM)

A phase 1 dose-escalation study of the oral selective inhibitor of nuclear export (SINE) KPT-330 (selinexor) in patients (pts) with relapsed/refractory acute myeloid leukemia (AML)

A phase 1 dose-escalation study of the oral selective inhibitor of nuclear export (SINE) KPT-330 (selinexor) in patients (pts) with heavily pretreated non-Hodgkin lymphoma (NHL)

Suchergebnisse filtern